Bayer | BAYN - Nettoeinkommen

Aktienkurs
38.05
Täglich Wechseln
1.60 4.39%
Monatlich
-3.39%
Jährlich
59.34%
Q2 Prognose
37.49




Nettoeinkommen Veränderung Datum
Air Liquide EUR 1.72B 84.3M 2025-12
Akzo Nobel EUR 93M 505M 2026-03
Alcon AG USD 217M 20M 2025-12
Amarin USD -1.22M 6.51M 2025-12
Arkema EUR -92M 127M 2025-12
AstraZeneca USD 3.08B 754M 2026-03
BASF EUR 560M 388M 2025-12
Bayer EUR -3.76B 2.79B 2025-12
Beiersdorf EUR 387M 165M 2025-12
Corteva USD -552M 232M 2025-12
Covestro EUR -378M 331M 2025-12
Essilor EUR 928M 459M 2025-12
Fresenius EUR 361M 17M 2025-12
Fresenius Medical Care EUR 327M 52.2M 2025-12
Genmab DKK 31M 370M 2025-12
Givaudan CHF 479M 113M 2025-12
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
GRIFOLS EUR 98.25M 28.72M 2025-12
Henkel EUR 925M 185M 2025-12
Hikma Pharmaceutical USD 164M 45M 2025-12
Johnson Matthey GBP -18M 93M 2025-12
Linde USD 1.53B 399M 2025-12
Lonza CHF 426M 119M 2025-06
Merck EUR 319M 583M 2025-12
Novartis USD 3.16B 747M 2026-03
Nutrien USD 571M 107M 2025-12
Philips EUR 395M 211M 2025-12
PPG Industries USD 300M 153M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR 1.61B 2.42B 2026-03
SAP EUR 1.93B 86M 2026-03
Solvay EUR -95M 129M 2025-12
UCB EUR 1.08B 608M 2025-12
Umicore EUR 247.85M 111.15M 2025-12
Vinci EUR 3.01B 1.11B 2025-12